0801 ET - Citi downgrades CME Group to neutral from buy, saying a number a positive catalysts have recently played out for the derivatives marketplace. In a research note, Citi says it expects more muted top-line growth for CME this year after two years of double-digit revenue growth. Citi says that while it expects CME shares to hold, given the company's defensive qualities in what the analysts expect to be a volatile environment, it prefers to wait for a better entry point and/or clearer fundamental catalysts to put new money to work. Citi's CME target price goes to $250 from $255. CME Group down 0.1% premarket to $232.07. (colin.kellaher@wsj.com)
(END) Dow Jones Newswires
January 06, 2025 08:01 ET (13:01 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.